Connect with us

Tech

Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon

Published

on



CNBC Marathon explores why pharmaceuticals are so complicated in the United States.
Concerns over prescription drug prices have grown into a big political issue, with nearly one in four Americans saying it’s difficult to afford their medications, according to a March 2019 poll by the Kaiser Family Foundation. Pharmacies technically set their own prices for generic drugs, but there are other players involved that complicate the process.

Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023. Analysts overwhelmingly say it’s a smart business move, but it could also come with some risks.

Meanwhile, the U.S.’s approval of Biogen’s Alzheimer’s drug Aduhelm was heralded as a historic triumph in the fight against the memory-robbing disease. But so far, Biogen has reported only a fraction of Aduhelm revenue to meet Wall Street’s expectations. Patients and physicians have been torn over the drug’s murky clinical data and its high price tag. Aduhelm’s lackluster launch has been costly, forcing Biogen to take measures to keep the drug afloat.

For Covid-19 vaccine maker, BioNTech, they had little recognition outside of their hometown of Germany prior to the pandemic. Over a month and a half before the World Health Organization officially declared a pandemic, BioNTech CEO Uğur Şahin met with his wife, BioNTech’s co-founder and chief medical officer Özlem Türeci, and together they agreed to redirect most of the company’s resources to developing a vaccine. The founders were confident in the potential of their mRNA technology, which they knew could trigger a powerful immune response. That confidence wasn’t necessarily shared by the broader medical community. No mRNA vaccine or treatment had ever been approved before. But the couple’s timely breakthrough was actually decades in the making.

CNBC Marathon brings together the best of CNBC on YouTube.

Chapters:
00:00 Introduction
00:31 Why U.S. pharmacies overcharge (Published August 2021)
16:35 The rise of BioNTech (Published October 2021)
34:21 Why the biggest pharma company in the U.S. is breaking up (Published January 2022)
45:42 What’s the controversy behind Biogen’s Alzheimer’s drug? (Published January 2022)

» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC

About CNBC: From ‘Wall Street’ to ‘Main Street’ to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC

#cnbc

Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon

source

Continue Reading
48 Comments

48 Comments

  1. @Berley_1234

    December 20, 2023 at 9:07 pm

    why? it's simple = GREED. I'm a pharmacist that now consults in the Integrative Medicine industry, but even with supplements, people pay $5-10 to make it and then charge $100 to the patient. GREED

  2. @shank3986

    December 20, 2023 at 9:07 pm

    Until and unless the lobbyist does not stop populating the White house, this is not going to stop in USA. Seems like sponsored and supported by Government.

  3. @carlosgruges9464

    December 20, 2023 at 9:07 pm

    Your thoughtfulness and thoroughness contributed to speeding up my healing process. I wonder what could have become of me if you weren’t the one who handled my case. Thank you for curing my HSV1/2, #SRHEALUS channel…….. …… ………….❤❤❤

  4. @Continentalmunkey88

    December 20, 2023 at 9:07 pm

    Purchasing power parity is continental

  5. @snuppypuppy6693

    December 20, 2023 at 9:07 pm

    My lunch dates!

  6. @snuppypuppy6693

    December 20, 2023 at 9:07 pm

    The drug cartels have hijacked the major pharmaceutical companies by laundering their illicit gains, i.e. "money changing" their counterfeit drug money by becoming INSTITUTIONAL INVESTORS and MAJORITY SHAREHOLDERS via off-shore accounts funding hedge funds and private equity firms. People are now at the mercy of drug dealers who are poisoning us with illegal drugs and legal drugs.

  7. @paulsaragosa371

    December 20, 2023 at 9:07 pm

    Ima a crazy taxi driver popey

  8. @paulsaragosa371

    December 20, 2023 at 9:07 pm

    Gi joe government is sue

  9. @paulsaragosa371

    December 20, 2023 at 9:07 pm

    Yes and no bob hope

  10. @paulsaragosa371

    December 20, 2023 at 9:07 pm

    Health insurance is filing for bankruptcy on anything else an😢percent 99 percent of thy whole world

  11. @evgeniichulkov9459

    December 20, 2023 at 9:07 pm

    Medical doctors and pharmacist were slave traders in previous life.

  12. @wolf-uq9tb

    December 20, 2023 at 9:07 pm

    American politicians would rather spend the money on foreign aid.
    Than purchase prescriptions for its population.

  13. @jonnovember2136

    December 20, 2023 at 9:07 pm

    Crooks and money launderers😟💸

  14. @lw1zfog

    December 20, 2023 at 9:07 pm

    ‘sO coMPLicaTEd’
    😂🤣😂🤦🏽‍♂️🥴🤡
    corporate M$M seeks to menticide the plebs once more, smh.

  15. @maryhyson9783

    December 20, 2023 at 9:07 pm

    Drug companies are a mafia operation. Many people take too much overpriced ineffective drugs.

  16. @vladimirseven777

    December 20, 2023 at 9:07 pm

    Hooray, pandemic, we finally can make profit! Not it's time to make treatment against Pfizer vaccine. Despite their promises about self-destruction I still have allergic reaction to it after two years after shot.

  17. @laidbakc

    December 20, 2023 at 9:07 pm

    USA as a country at large is run as a big business. If you are having a businessman mentality you will be successful, if not – oh well…

  18. @user-rk2fm3bn3u

    December 20, 2023 at 9:07 pm

    ، Thank you

  19. @SentroPharmaHealthcare-lv5mz

    December 20, 2023 at 9:07 pm

    👍

  20. @follout7075

    December 20, 2023 at 9:07 pm

    Sounds like a racket to me 😂

  21. @joelkikkert24

    December 20, 2023 at 9:07 pm

    The problem is political landscape. We don't have this issue in Europe, we just determine the prices pharma can sell medicines at. It's not rocket science, just greed.

  22. @robinperronjones5024

    December 20, 2023 at 9:07 pm

    It’s part of the US national sport of GREED

  23. @WheelerRickTHETIEGUY

    December 20, 2023 at 9:07 pm

    I tried mail…and for me…👎👎👎

  24. @angelvaldez8048

    December 20, 2023 at 9:07 pm

    In a simple Google search, I ask what is the cure to schizophrenia or bipolar for example and it says in the medical websites that there's no cure for any mental illnesses at this time. I think the medical system especially in the U.S. is broken. Why is it understandable and acceptable and moral for psychiatrist or any other doctors to take money from "sick" clients to "treat" diseases they don't really understand? Then as society we're suppose to keep upholding these doctors and pay them a lot of money! It makes no sense. It's medical abuse and a cycle of violence to be expected to pay doctor's for services when they don't provide the answer. What is the solution, the cure, the remedy, the answer to mental illness? Is it really a lifelong sentence of taking medication? Is it to put a person in a psychiatric hospital, force them to "try" all these different medications and experimenting on them to an extent, and then putting them in a life long relationship with a psychiatrist, a pharmacist, and prescription medication? I find the medical system here in the U.S. to be a business model: not designed to get people well again but to keep them in a toxic relationship. How can a person be free when they are 100% dependent on medication which is also backed by a well paid doctor? This paradigm is how to chain a sick person into a cycle of medical misconduct. Why is it like this here anyway? Is the U.S. only based on paychecks/salaries. No one cares anymore about doing what is right and that's to give people back their lives where their freedoms aren't taken away by this corrupt medical system. I believe their should be higher standards and better expectations than greed.

  25. @TheAb9211

    December 20, 2023 at 9:07 pm

    Set a maximum retail price for each medication based on a limit of profit margin. Let the pharmacies negotiate with the companies for profit margins, since the max price is already decided, consumer benefits while the companies can fight for their margins, simple. It isn’t rocket science people.

  26. @AeschylusShepherd

    December 20, 2023 at 9:07 pm

    They profit because the government allowed it!

  27. @epidermiuss

    December 20, 2023 at 9:07 pm

    BS propaganda

  28. @fabioraniery6950

    December 20, 2023 at 9:07 pm

    why does everything have to be so complicated in the US?

  29. @theholyquranintonation1194

    December 20, 2023 at 9:07 pm

    😊😮

  30. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    Long term potential to attract girls with money gucci gucci gucci

  31. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    It's all a big money boy pyramid in stem.

  32. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    I love the irony of a Harvard med school professor explaining that societies brain can't keep up with his. Gucci gucci gucci smart harvard professor money money money!

  33. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    As long as their covid mask war is successful their employees will keep getting rich!

  34. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    The same people who fight for covid masks in public places are okay with people abusing opiates at home.

  35. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    Johnson and Johnson fueled the opioid crisis no surprises there.

  36. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    Donald trump has good financial strength and cash flows.

  37. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    Johnson and Johnsons base lives in Wisconsin.

  38. @JamesVestal-dz5qm

    December 20, 2023 at 9:07 pm

    Yesterday I drank too much coffee and studied nothing but advanced transport phenomena so today I'm sick in bed.

  39. @cristinad4835

    December 20, 2023 at 9:07 pm

    All the medical and farmaceutical mafia of Rockefeller…Rotchild…must be arrested for crimes against humanity

  40. @nellienewyork

    December 20, 2023 at 9:07 pm

    I worked as a pharmacy technician from 1998 to 2005 in a loca moms and pops pharmacy. I refused to uses one of this big pharmacy. I will not… period

  41. @weefyman7330

    December 20, 2023 at 9:07 pm

    All poisons, justice will be swift, i won't bat an eyelid.

  42. @jackli6592

    December 20, 2023 at 9:07 pm

    people need to educated for drug price, the ONLY reason pharmacies and pharmaceuticals able to charge as high as they want is because customers are not INFORMED with price. how many of you actually ask the price of the prescriptions when you send it to the pharmacy? if we all start asking the price, these price will come down. an example an antibiotic drug i had years ago at a Walgreen was 95buck. the same exact drug at Wal-Mart is 4.50. i was so stunned when i pick up the prescription thought they might made a mistake. if there is walmart around GET YOUR PRESCRIPTION from them, with insurance or without insurance they are dirt cheap on the generic brand compare to blood suckers like CVS and walgreen.

  43. @TheAvtrey

    December 20, 2023 at 9:07 pm

    I love free market capitalism ruling over healthcare. All hail shareholders!

  44. @AllThingsIzzyTTV

    December 20, 2023 at 9:07 pm

    The 🧢

  45. @alxl6385

    December 20, 2023 at 9:07 pm

    It's not complicated. Americans are being murdered and fleeced for profit. End of discussion.

  46. @bodyheals

    December 20, 2023 at 9:07 pm

    Bulzhit proper gander

  47. @mastercreamer1398

    December 20, 2023 at 9:07 pm

    I just like to get high and chill

  48. @mastercreamer1398

    December 20, 2023 at 9:07 pm

    Where do they keep the pain pills at?

Leave a Reply

Your email address will not be published. Required fields are marked *

Tech

Why There’s An ‘Extremely Fierce’ Battle For TSMC’s Limited Chip Manufacturing Capacity

Published

on

By



Unstoppable demand for AI is leading to a capacity crunch on factory lines at the world’s leading chip manufacturer, Taiwan Semiconductor. And it could put a chokehold on AI’s ability to scale. Analysts tell CNBC that Nvidia, Apple, Broadcom, AMD and others are locked in an “extremely fierce” competition to get their GPUs, CPUs and custom AI chips made at TSMC. Capacity can’t come online fast enough, despite TSMC’s rush to build new fabs in Taiwan, Japan and Arizona, where has expanded investment to $265 billion. The strain has made one man at TSMC “the most popular person on the planet,” as chip start-ups and big name CEOs visit Taiwan to ask him for wafer allocation. It’s also created a rich opportunity for Intel, as customers look to the long-struggling foundry arm of the U.S. chip manufacturer for a second source.

Chapters:
0:00 Introduction
2:06 ‘Most popular person on the planet’
6:54 Making room for smaller players
9:10 Can new U.S. fabs ease the crunch?

Producer and Reporter: Katie Tarasov
Edited by: Matt Soto, Andrew Evers
Camera: Eddie Temborski, Robert Lampe, Evan Reinhardt
Senior Director of Video: Jeniece Pettitt
Animation: Jason Reginato, Emily Park
Additional Footage: Cerebras, D-Matrix, Getty Images, Intel, Nvidia, OpenAI, SpaceX, TSMC

» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision

About CNBC: From ‘Wall Street’ to ‘Main Street’ to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Want to get ahead at work? Then you need to learn how to make effective small talk. In CNBC’s new online course, How To Talk To People At Work, expert instructors teach you how to use everyday conversation to gain visibility, build meaningful relationships and advance your career. Sign up now: https://cnb.cx/4sGlSkh

Connect with CNBC News Online
Get the latest news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

#CNBC

Why There’s An ‘Extremely Fierce’ Battle For TSMC’s Limited Chip Manufacturing Capacity

source

Continue Reading

Tech

Why Warner Records is investing in South Asian artists

Published

on

By



Warner Music Group, the third-largest music label by market share, is tapping into the South Asian music movement with its latest venture.

CNBC’s Laya Neelakandan explains.

source

Continue Reading

Tech

How Micron’s massive buildout made Boise a boomtown

Published

on

By



Micron’s hometown of Boise, Idaho has a growing crop of newly minted millionaires.

The AI-driven memory boom is showing up in the form of job growth, new construction projects, a bustling dining scene and an influx in new residents.

CNBC’s Katie Tarasov explains. Find the full report in related video.

source

Continue Reading

Tech

How dating became a financial luxury

Published

on

By



Half of single Americans say they are going on fewer dates or choosing less expensive activities because of rising costs, according to BMO’s 2026 survey.

But, the cost of dating itself is only part of the story. For millions of users, finding a date means paying for the apps.

Watch the full story in related video.

source

Continue Reading

Tech

The Megadonors Funding The 2026 Midterms

Published

on

By



Billions of dollars have been raised for this year’s midterms elections, with a significant portion coming from big name tech billionaires in the cryptocurrency, artificial intelligence and online gambling sectors. Megadonors’ contributions are overwhelmingly behind Republicans in the 2026 midterm election, with 14 of the 20 largest donor groups exclusively or nearly exclusively backing GOP candidates or outside groups. CNBC’s Luke Fountain reports.

Chapters:
00:00 – 00:56 Introduction
00:57 – 03:37 Chapter 1 – Republican-aligned donors
03:38 – 05:07 Chapter 2 – Democrat-aligned donors

Reporter: Luke Fountain
Produced and Edited by: Romy Tarantino
Animation: Jason Reginato, Emily Park
Additional Camera: Macklin Fishman, Andrew Evers
Supervising Producer: Shawn Baldwin
Additional Footage: Getty Images

» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision

About CNBC: From ‘Wall Street’ to ‘Main Street’ to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Want to get ahead at work? Then you need to learn how to make effective small talk. In CNBC’s new online course, How To Talk To People At Work, expert instructors teach you how to use everyday conversation to gain visibility, build meaningful relationships and advance your career. Sign up now: https://cnb.cx/4sGlSkh

Connect with CNBC News Online
Get the latest news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

#CNBC

The Megadonors Funding The 2026 Midterms

source

Continue Reading

Trending

On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.